SCHEMBL3358435

SCHEMBL3358435

CCOC1CCC(COc2ccc(/C=C/C(=O)O)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.49
THRB P10828 1/20 0.48
ATM Q13315 1/20 0.48
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.46
PARP15 Q460N3 1/20 0.45
PARP10 Q53GL7 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAOB P27338 4/20 0.43
MAOA P21397 1/20 0.43
GAA P10253 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.42
FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3358439 1.00 POLB (0.49) POLBTHRBATMKMT2AKDM4E
SCHEMBL3357994 0.92 POLB (0.46) POLBTHRBATMKMT2AKDM4E
SCHEMBL3357986 0.92 POLB (0.46) POLBTHRBATMKMT2AKDM4E
SCHEMBL3356734 0.91 POLB (0.46) POLBTHRBATMKMT2AKDM4E
SCHEMBL3356744 0.91 POLB (0.46) POLBTHRBATMKMT2AKDM4E
SCHEMBL3359960 0.89 THRB (0.52) POLBTHRBATMKMT2AKDM4E
SCHEMBL3359963 0.89 THRB (0.52) POLBTHRBATMKMT2AKDM4E
SCHEMBL3356502 0.89 POLB (0.44) POLBTHRBATMKMT2AKDM4E
SCHEMBL3356507 0.89 POLB (0.44) POLBTHRBATMKMT2AKDM4E
SCHEMBL3361329 0.88 THRB (0.51) POLBTHRBATMKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
EP-2152660-B1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2016-05-11 EP disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 POLB 794/4885THRB 4854/4885ATM 2265/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 POLB 794/4885THRB 4854/4885ATM 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.